BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32236568)

  • 1. miR‑539 suppresses the proliferation, migration, invasion and epithelial mesenchymal transition of pancreatic cancer cells through targeting SP1.
    Xue L; Shen Y; Zhai Z; Zheng S
    Int J Mol Med; 2020 Jun; 45(6):1771-1782. PubMed ID: 32236568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.
    Cui F; Wang S; Lao I; Zhou C; Kong H; Bayaxi N; Li J; Chen Q; Zhu T; Zhu H
    Oncol Rep; 2016 Jul; 36(1):487-93. PubMed ID: 27222350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
    Yang Y; Tao X; Li CB; Wang CM
    Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
    Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
    Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.
    Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP
    Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2.
    Zhang Z; Che X; Yang N; Bai Z; Wu Y; Zhao L; Pei H
    Biomed Pharmacother; 2017 Dec; 96():1341-1348. PubMed ID: 29196101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
    Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
    Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-217 inhibits cell proliferation, invasion and migration by targeting Tpd52l2 in human pancreatic adenocarcinoma.
    Chen Q; Wang P; Fu Y; Liu X; Xu W; Wei J; Gao W; Jiang K; Wu J; Miao Y
    Oncol Rep; 2017 Dec; 38(6):3567-3573. PubMed ID: 29039566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
    Sun B; Fan Y; Yang A; Liang L; Cao J
    J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA‑539 inhibits the proliferation and invasion of bladder cancer cells by regulating IGF‑1R.
    Liao G; Chen F; Zhong J; Jiang X
    Mol Med Rep; 2018 Apr; 17(4):4917-4924. PubMed ID: 29393438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.
    Park YR; Seo SY; Kim SL; Zhu SM; Chun S; Oh JM; Lee MR; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 14. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y; Wang F; Wang L; Zhang Q
    World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA UCA1 induced by SP1 and SP3 forms a positive feedback loop to facilitate malignant phenotypes of colorectal cancer via targeting miR-495.
    Liu SJ; Li ZQ; Wang XY; Liu F; Xiao ZM; Zhang DC
    Life Sci; 2021 Jul; 277():119569. PubMed ID: 33961855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of microRNA-183 on epithelial-mesenchymal transition, proliferation, migration, invasion and apoptosis in human pancreatic cancer SW1900 cells by targeting MTA1.
    Lin X; Zheng L; Song H; Xiao J; Pan B; Chen H; Jin X; Yu H
    Exp Mol Pathol; 2017 Jun; 102(3):522-532. PubMed ID: 28506766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer.
    Zang W; Wang Y; Wang T; Du Y; Chen X; Li M; Zhao G
    Mol Cancer; 2015 Feb; 14():37. PubMed ID: 25744894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA-223 inhibits epithelial-mesenchymal transition in gastric carcinoma cells via Sp1.
    Hu J; Shan Z; Hu K; Ren F; Zhang W; Han M; Li Y; Feng K; Lei L; Feng Y
    Int J Oncol; 2016 Jul; 49(1):325-35. PubMed ID: 27212195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
    Ye ZH; Gui DW
    Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.